BCA
AMRX icon

Berman Capital Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

Berman Capital Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
+329
New +$1.66K ﹤0.01% 1794

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berman Capital Advisors's AMRX Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2021: 329 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1794 among its holdings.

154 funds tracked by Wall St. Rank hold AMRX as of Q3 2021.

  • Berman Capital Advisors held 329 shares of Amneal Pharmaceuticals worth $1K as of Q3 2021.
  • Amneal Pharmaceuticals was a new Berman Capital Advisors position in Q3 2021.
  • Amneal Pharmaceuticals made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1794 holding.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.